iPhone | iPad
Android
Huawei
The strong dollar continues weighing on gold appetite, say analysts
KT APPDOWNLOAD
Putin lauds AstraZeneca as it signs Covid vaccine tie-up deal with Russia
Moscow - Russia wants to produce the new vaccine jointly if it is proven to be effective.
Russian President Vladimir Putin on Monday hailed British drugmaker AstraZeneca's decision to test combining its own experimental Covid-19 vaccine with Russia's Sputnik V shot, as Moscow said the start of clinical trials was imminent.
Putin was speaking by video conference at a virtual event that saw AstraZeneca sign a memorandum of cooperation with Russia's Gamaleya Institute, which developed Sputnik V, Russia's RDIF sovereign wealth fund, and Russian drugmaker R-Pharm.
Clinical trials, still under way, have shown Sputnik V has an efficacy rate of over 90 per cent, higher than that of AstraZeneca’s own vaccine and similar to those of US rivals Pfizer and Moderna.
Putin praised Pascal Soriot, AstraZeneca's chief executive, who had dialled in by video conference.
"I want to single out your pro-active stance to achieve goals that are highly important, not just for your company, but in reality and without excessive bombast or exaggeration, for humanity," said Putin.
Kirill Dmitriev, the head of RDIF, told the event that clinical trials combining the Russian and British vaccines would start soon in three countries.
Dmitriev has previously said Russia believes the combination will boost the efficacy of the AstraZeneca vaccine.
Kate Bingham, chair of Britain’s vaccine task force, said this month the UK would start trials next year using combinations of different kinds of vaccine for the initial and booster vaccinations, in the hope that a “mix-and-match” approach might maximise the immune response.
The cooperation between one of Britain’s most valuable listed companies and the state-backed Russian research institute highlights the pressure to develop an effective shot to fight the pandemic, which has killed over 1.6 million people.
In Moscow, the move is seen as a long-awaited vote of confidence by a Western manufacturer in Sputnik V, which Russian authorities say is the target of a foreign-backed smear campaign.
Russia wants to produce the new vaccine jointly if it is proven to be effective.
Dmitriev, head of RDIF, which has financed and promoted Sputnik V, also announced on Monday that Russia believed Sputnik was highly effective against a new strain of the coronavirus found in Europe.
He said neighbouring Belarus would begin producing the Russian vaccine in the first quarter of next year and that Kazakhstan had started production.
Foreign manufacturing facilities would produce more than 500 million doses of the Russian vaccine next year, said Dmitriev.
More news from
Authorities say minors between the ages of 1 and 17 were hit, along with five adults between 25 and 65
Analysts expect Opec could spring a surprise in June 4 meeting by slashing output, similar to one announced in April
Forex traders said downward movement in crude price and inflows of foreign funds, however, capped the fall in the Indian currency
A photo posted to social media shows the actress lying in a hospital bed, attached to what appears to be an IV drip
By spending only Dh50, Rinu entered the draw that made him a multi-millionaire overnight
Paramilitary teams and the State Disaster Response Fund (SDRF) are helping police with evacuation and rescue operations
After Jadeja secured the victory for CSK, cameras captured a rare sight - a tear or two in the eyes of 'Captain Cool'